Gianluca Baroni-Svegliati

Ancona, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications

Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.

ITA-MASLD: A national observational study to characterize the profile of patients with MASLD in specialistic care in Italy.

Showing 1-12 of 115

Last Updated: 09/26/2026